Master Slide Current Trends in the Pharmacological Treatment of Autism Alexander Kolevzon, MD Peter Della Bella, MD David Grodberg, MD Charles Cartwright,

Slides:



Advertisements
Similar presentations
Pharmacologic Treatments. 2 Cognitive Behavioural Therapy (CBT) Psychosocial Interventions.
Advertisements

WADA’s Prohibited Substance List: A Psychiatric Perspective 15 th FINA World Sports Medicine Congress Indianapolis, October 12 th, 2004 Presenter – Saul.
Advanced Psychopharmacology: AACAP Meeting Oct.18-23, 2005 Chanvit Pornnoppadol, M.D.
GENERALIZED ANXIETY DISORDER IN PRIMARY CARE Curley Bonds, MD Medical Director Didi Hirsch Mental Health Services Professor & Chair Charles R. Drew University.
Disorders of Childhood 12/2/02. Pervasive Developmental Disorders Severe childhood disorders characterized by impairment in verbal and non-verbal communication.
Overview of Mental Health Medications for Children and Adolescents Module 5 ADHD and Disruptive Behavior Disorders 1.
Intro to Psychopharmacology Caitlin Stork, MD. Besides dopamine blockade... ReceptorEffect of Blockade Acetylcholine (muscarinic; M1) Anticholinergic.
Care of Children and Adolescents With Psychiatric Disorders Chapter 26.
FASD: Co morbid psychiatric conditions and psychopharmacology Dr. Terri Erwin Assistant Professor of Psychiatry Division of Child and Adolescent Psychiatry.
PSYCHIATRIC COMORBITY IN AUTISM Teresita M. Amay, M.D. Diplomate American Board of Psychiatry and Neurology.
Dr K Razjouyan Associate Professor of Shahid Beheshty University and Medical Sciences.
Obsessive Compulsive Disorder. Features of OCD Obsessions Obsessions –Recurrent and persistent thoughts; impulses; or images of violence, contamination,
OCD Facts *All facts obtained through DynaMed Database or ocdeducationstation.org.
OCD Questions and answers. Sources are DSM-IV-TR, APA Practice Guideline, or Sadock and Sadock, 10 th edition unless otherwise indicated. As of 1Sep08.
Asperger’s Disorder Ashleigh Pogue and Kayla Roth.
Brian Bushart MS and Martha Rich RN, ANP Keuka College.
Anxiety in Autism Spectrum Disorders Todd Levine MD, FAAP Assistant Professor in Psychiatry and Human Behavior Brown Center for the Study of Children at.
The Important Questions to Ask Before Considering Medications Michael J. Murray, M.D. Penn State College of Medicine Milton S. Hershey Medical Center.
Chapter 7 Autism Spectrum Disorders
Autism Spectrum Disorders and Mental Health BETTINA STOTT Surrey Branch Conference October 2007 AB C.
Working with Students with Asperger’s Syndrome.  A developmental disorder  Part of the autism spectrum disorders  Communication and socialization 
Marcie Hall, M.D. Department of Child and Adolescent Psychiatry University Hospitals Case Medical Center Autism Summit October 10, 2008 Medication Use.
1 Dementia. 2 Phenomenology Dementia P Disorder of Cognitive Function.
Autism Spectrum Disorders: Presentation During School Years Rhea Paul, Ph.D., CCC-SLP Southern Connecticut State University Yale Child Study Center Feb.
COMORBIDITY By Larry B. Silver, M.D.. THERE IS A CONTINUUM OF NEUROLOGICALLY-BASED DISORDERS THAT ARE OFTEN FOUND TOGETHER If any one of the disorders.
Psychoactive Medications and ASD. Considering Pharmacologic Intervention Why would we consider using psychopharmacologic agents to treat problems in a.
Pediatricians as Primary Mental Health Professionals 5 Essential Drugs Dr. M.K.C.Nair Director, Child Development Centre Medical College, Tvpm Dr. Paul.
Autism Lisa A. Tobler, MS. Reading Visual Impairments in Infancy, p. 178 Developmental Delay, p. 226 Autism, p. 289 ADHD, p Eating Disorders,
UNIT 1 PPRESENTATION ASPERGER DISORDER Presenters: Dr Mala Dr Suzanna Mwanza Moderator: Dr Mpabalwani.
Early Onset of Schizophrenia Spectrum Disorder l Premorbid history l Attention problems l Social impairment l Language abnormalities.
Autistic Spectrum Conditions
Incidence of Autism Spectrum Disorders Jean A. Frazier, MD Executive Director, Eunice Kennedy Shriver Center Robert M. and Shirley S. Siff Chair in Autism.
Update on Pharmacotherapies for PTSD Michelle Pent, MD, MPH April 29, 2011.
OCD, PTSD, and Panic Disorders. OCD Biological basis remains unknown But there seems to be some genetic component related to OCD and other anxiety disorders.
PSYCHIATRIC DRUGS Chapter 13. Psychiatric Drugs  Treat mood, cognition, and behavioral disturbances associated with psychological disorders  Psychotropic.
Maryam Tabatabaee M.D Assistant professor of psychiatry.
Cardiometabolic Consequences of Risperidone in Children with Autism Cardiometabolic Consequences of Risperidone in Children with Autism Susan J. Boorin,
Drugs Used in Autism and Other Neurological diseases.
Copyright © 2002 by W. B. Saunders Company. All rights reserved. Chapter 31 Disorders of Children and Adolescents Menu F.
Autism Spectrum Disorders
Treating Mental Illness Bittu Majmudar September 25, 2007 Neuroethics.
Neurodevelopmental Disorders
Defining Psychological Disorders. Psychological Disorder: What Makes a Behavior “Abnormal”? Anxiety and Dissociative Disorders: Fearing the World Around.
Isahel N. Alfonso, R.N.  Selective Serotonin Reuptake Inhibitor (SSRI) Fluoxetine Fluvoxamine Paroxetine Sertraline Citalopram  Tricyclic Compound (TCA)
Obsessive- Csompulsive Disorder ( 25/9/2013 ) Elham aljammas.
행동치료의 의학적 처방 Hyun S. Park, MD Developmental and Behavioral Pediatrician Neurodevelopmental Center, For OC Kids Assistant Clinical Professor of Pediatrics,
Autisitic Spectrum Disorder Child Psychiatry 8 th Dec 2015 Tuesday Dr. Sami Adil 1.
What we will learn today:  Definition of autism  Ranges of autism  Causes  Symptoms  Diagnosis  Treatment  Facts Vs. Myths At the end of this lesson.
Autism (autism spectrum disorder) 2/26/16 By, Breah, Kourtney, Tyson, Marshall.
Pharmacotherapy in Children with Learning Disability Dr. Paramala J Santosh Honorary Senior Lecturer in Child & Adolescent Psychiatry Institute of Child.
ALL ABOUT AUTISM We Care Services. WHAT IS AUTISM?  Autism is a serious developmental disorder that challenges the ability to communicate and interact.
Drugs Used in Autism and Other Neurological diseases Dr. Yieldez Bassiouni.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparative Mortality Risk in Adult Patients With.
Psychopharmacology of Autism Spectrum Disorder
COMPLEXITIES OF AUTISM SPECTRUM DISORDER
Generalized Anxiety Disorder
Child and Adolescent Mental Health prof. Elham Aljammas 19/3/2014
Obsessive Compulsive Disorder (OCD) Abdulaziz S. Alsultan
CHILD PSYCHIATRY Fatima Al-Haidar
Childhood (Neurodevelop-mental) Disorders
Disorder Treatment Psychotherapies “Talk Therapies”
Autism.
Michael Panzer, MD ThedaCare Behavioral Health
Disorder Treatment Psychotherapies “Talk Therapies”
Child, Adolescent & Adult Psychiatrist
Obsessive-Compulsive Disorder: Pharmacotherapy
Disorder Treatment Psychotherapies “Talk Therapies”
PHARMACOTHERAPY - I PHCY 310
Obsessive Compulsive Disorder
Presentation transcript:

Master Slide Current Trends in the Pharmacological Treatment of Autism Alexander Kolevzon, MD Peter Della Bella, MD David Grodberg, MD Charles Cartwright, MD

Symptom Domains and Associated Features of ASD Social Impairment Repetitive Behaviors Speech/ Communication Deficits Social Phobia Asperger’s syndrome Obsessive Compulsive Disorder AUTISM Impulsivity/ Aggression Expressive/Receptive Language Disorders EEG Abnormalities ADHD Symptoms

Peter Della Bella, MD Director of Clinical Programs Premier HealthCare Treating Agitation and Aggression in People with ASDs

ADHD Symptoms and Autism Spectrum Disorders: Co-Occurrence, Phenomenology, and Treatment David Grodberg, M.D David Grodberg, M.D. Seaver Autism Center

The Treatment of Anxiety and Repetitive Behaviors in Autism Spectrum Disorders Alex Kolevzon, M.D Alex Kolevzon, M.D. Clinical Director, Seaver Autism Center

Future Directions Targeting Novel Neurotransmitter and Hormonal Systems In Autism Charles Cartwright, MD Director, YAI Autism Center

Master Slide Agitation and Aggression Peter Della Bella, MD

What is Agitation? An inability to cope causing distress… and losing control Precursors: Irritability, anxiety, fatigue… The worry: add a trigger and…

What is Aggression? (Latin) Attack Premeditated vs. loss of impulse control

Understanding the Roots of Agitation and Aggression

Roots of Irritability & Agitation - the Fight or Flight Response Sources: Babble.com; Brain-trainer.com; quantumlearningblog

Roots of Agitation and Aggression irritated c a l m agitated ATTACK coping loss of control

Roots of Agitation and Aggression Survival instinct (“Boxed into a corner”) Pain/physical discomfort (sensory integration) Psychic discomfort (stress, change, frustration)

Roots of Agitation and Aggression irritated c a l m agitated ATTACK

Roots of Agitation and Aggression c a l m / irritated agitated ATTACK stress, discomfort, pain

Roots of Agitation and Aggression c a l m / irritated agitated ATTACK stress, discomfort, pain cultural, behavioral, “medical” factors

What do you do? Survival instinct…….. take care of the threat Treat sources of physical discomfort, side effects… proper medical evaluation sensory integration principles Treat sources of psychic discomfort….. soften the blow of change address stress (sleep, food, downtime, fun)

Roots of Agitation and Aggression Irritated c a l m agitated ATTACK

When do you use meds? When there are underlying biological factors. Let the symptoms guide you! Anxiety Disorder Depression ADHD Psychosis Seizure Otherwise, MEDICATION IS A LAST RESORT

FDA approved for autism…

So what do we use? Antipsychotics Risperidone, aripiprazole Olanzapine Quetiapine Chlorpromazine Haloperidol Thioridazine Clozapine Anti-Fight or Flight Meds Clonidine Guanfacine Beta-blockers: propranolol Anti-epileptics & Mood Stabilizer ValproateCarbamazepine Oxcarbazepine Lithium Anti-anxiety Benzodiazepines: Clonazepam Lorazepam Diazepam BuspironeSSRIs: Fluoxetine Paroxetine Sertraline Fluvoxamine Citalopram/ Escitalopram

What are the pros and cons of using medications?

Master Slide Attention Deficit and Hyperactivity David Grodberg, MD

ADHD SYMPTOMS IN ASD DSM-IV TR prohibits diagnosis of ADHD and ASD in the same individual Clinic based surveys indicate that Sx c/w ADHD present in % of children with ASD

ADHD SYMPTOMS IN ASD Asperger’s Disorder, PDD-NOS who meet full criteria for ADHD Autistic Disorder with ADHD-like symptoms, which are part of core features of autism Autistic Disorder with increased motor activity, impulsivity, inattention

ADHD SYMPTOMS IN ASD Inattention to social stimuli but good sustained focus on interests or objects. NOT ADHD. Hyperactivity as a manifestation of motor stereotypy, social anxiety, agitation, or medication side effects. NOT ADHD

TREATMENT OF ADHD SYMPTOMS IN ASD Strongest evidence: methylphenidate –2 placebo-controlled trials –retrospective and prospective effectiveness study

Methylphenidate Increases NE and DA by blocking reuptake

Methylphenidate ASD+ADHD tolerated stimulants generally well ASD+ADHD had dysphoria and obsessionality - initiate methylphenidate in ASD at lower dose and increase dose slowly with frequent monitoring for side effects

TREATMENT OF ADHD SYMPTOMS IN ASD Moderate Level Evidence: guanfacine –chart review study –small open-label trial Moderate Level Evidence: atomoxetine –small open label study –small placebo controlled study

Guanfacine Alpha 2A agonist. Enhances prefrontal cortical function

Atomoxetine Increases NE and DA in prefrontal cortex.

TREATMENT OF ADHD SYMPTOMS IN ASD Weak Support: clonidine, donepezil –very small studies

Clonidine Nonselective alpha2 agonist. More sedating/hypotensive.

Donepezil Acetyl Cholinesterase inhibitor

SUMMARY Children with ADHD symptoms and ASD are difficult to treat stimulants (methylphenidate), atomoxetine, alpha-agonists are effective SSRIs and atypical neuroleptics are used to address other types of symptoms

CLINICAL PEARLS If a child with ADHD is referred with poor response to meds and/or significant side effects (anxiety, stereotypy, aggression) - look for evidence of previously unrecognized ASD If a stimulant is helpful but side effects of anxiety emerge, can switch to atomoxetine or add SSRI. Monitor closely for behavioral disinhibition –hyperactivity, impulsivity, new odd/disorganized behavior, SI.

Master Slide Anxiety and Repetitive Behaviors Alexander Kolevzon, MD

Repetitive Behaviors A preoccupation with stereotyped and restricted patterns of interest Inflexibility in adhering to routines and rituals Stereotyped and repetitive motor mannerisms Persistent preoccupation with parts of objects Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)

Repetitive Behaviors Lower Order (motor/sensory) Repetitive self-injury Motor stereotypies Sniffing/mouthing objects Touching Tapping Rubbing Higher Order (compulsive) Insistence on sameness Ritualistic behavior Circumscribed interests & preoccupation

Repetitive Behaviors Lower Order (motor/sensory) Hoarding Higher Order (compulsive) Obsessions Anagnostou et al, 2005

Serotonin System  Critical to neurodevelopment  Directs neuronal growth, proliferation, differentiation  Widely expressed in emotional centers of brain

Emotional Center of Brain

Serotonin Pathways

Serotonin System in Autism

Serotonin Reuptake Inhibitors

Serotonergic Medications

Medication Open Label Controlled fluoxetine fluvoxamine+ sertraline citalopram+-- escitalopram+ venlafaxine + + clomipramine+ buspirone

Study of Fluoxetine in Autism (SOFIA) N=158

Atypical Antipsychotics - Risperidone McDougle et al, 2005

Atypical Antipsychotics – Abilify Marcus et al, 2009

Novel Therapeutics - Oxytocin Widely distributed in Central Nervous System; especially emotional centers Peripheral release is important for delivery and lactation Central release is important for social cognition (recognition and memory); trust; social attachment; maternal bonding

IV Oxytocin Challenge  need to know  repeating  ordering  need to tell  self-injury  touching Hollander et al, 2003

Master Slide Future Directions Charles Cartwright, MD

All Treatments Discussed are Off Label and do not have FDA Approval for the Treatment of Autism

The Glutamate System

Machado-Vieira et al, 2009

Glutamate Modulating Treatments

D-Cycloserine

D-Cycloserine in the Treatment of Autism Posey et al, 2004

Riluzole

Riluzole in the Treatment of OCD Coric et al, 2005

N-acetylcysteine

N-acetylcysteine in the Treatment of Trichotillomania Grant et al, 2009

Treatments that involve Hormones

Oxytocin

Andari et al, 2010

Caution Demonstrate Safety and Efficacy

Master Slide THANK YOU